News Search Results
Feb 23, 2026, 17:00 ET Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
responsible for 60% and Vir Biotechnology responsible for 40% of all costs. Vir Biotechnology will continue the ongoing Phase 1 trial, until responsibility is transitioned to Astellas, after which Astellas will be responsible for all development activities. In the U.S., Vir Biotechnology will have the option
More news about: Astellas Pharma Inc.
Feb 23, 2026, 16:05 ET BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results
Conference ID: 4503000 About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based
More news about: BioMarin Pharmaceutical Inc.
Feb 23, 2026, 16:00 ET New ACVIM Consensus Statement Highlights Visbiome Vet's De Simone Formulation in Diet-First Approach
https://academic.oup.com/jvim/article/40/1/aalaf017/8429723About ExeGi Pharma ExeGi Pharma LLC is a biotechnology company specializing in the development and commercialization of live biotherapeutic drugs for humans and probiotic agents for both humans and pets. With
More news about: ExeGi Pharma
Feb 23, 2026, 13:12 ET Rubin Rudman Partner David Wittmann Named a 2026 "Go To Business Transaction Lawyer" by Massachusetts Lawyers Weekly
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Feb 23, 2026, 12:53 ET PorTal Access, Inc. Appoints Industry Veteran David Snow to Board of Directors to Advance Next-Generation Oncology Vascular Access Solutions
Inc., a pioneering medical device startup developing advanced vascular access solutions for oncology, announced today that David Snow, a seasoned biotechnology and pharmaceutical executive, has joined its Board of Directors. Snow's appointment strengthens the company's leadership as it advances the development
More news about: PorTal Access, Inc.
Feb 23, 2026, 11:00 ET Stäubli Robotics Showcases New Sterimove at INTERPHEX 2026
RoboticsStäubli Robotics is a leading global provider of advanced industrial automation solutions. With decades of expertise across pharmaceuticals, biotechnology, medical device manufacturing, and high‑precision industrial sectors, Stäubli's robotic platforms are engineered for performance, reliability, and
More news about: Staubli Corporation
Feb 23, 2026, 10:30 ET Viral Vectors and Plasmid DNA Manufacturing Market to Reach $34.0 billion by 2033 at 20.4% CAGR: Allied Market Research
acquisitions enable companies to broaden their technology portfolios and enter adjacent markets quickly. Long-term strategic partnerships with biotechnology developers, academic research centers, and pharmaceutical firms provide steady demand and collaborative innovation opportunities. Partnerships can
More news about: Allied Market Research
Feb 23, 2026, 10:24 ET The HWP Group Announces Acquisition of Global Market Access Solutions
clients and patients alike."This acquisition further solidifies the position of HWP as a full‑service strategic partner to pharmaceutical and biotechnology companies navigating increasingly complex global markets, where clinical excellence must be matched by compelling economic evidence to achieve reimbursement,
More news about: Health & Wellness Partners
Feb 23, 2026, 10:01 ET Global Fluoropolymer Market to Reach US$16.7 Billion by 2033, Growing at 5.1% CAGR - Persistence Market Research
Nanofiltration), Application (Water & Wastewater Treatment, Desalination, Industrial Processing, Food & Beverage Processing, Pharmaceutical & Biotechnology, and Misc.), and Regional Analysis for 2026 – 2033
More news about: Persistence Market Research Pvt. Ltd.
Feb 23, 2026, 10:00 ET THE LOCKWOOD GROUP WELCOMES TOTAL HEALTH
continuum.About The Lockwood GroupThe Lockwood Group is a global health care services organization that partners with pharmaceutical, biotechnology, and health care companies to translate complex science into compelling, measurable strategies. With integrated capabilities spanning medical communications,
More news about: The Lockwood Group
Feb 23, 2026, 09:36 ET NASDAQ: QURE INVESTOR ALERT: Berger Montague Advises uniQure N.V. (NASDAQ: QURE) Investors of an April 13, 2026 Deadline
CLICK HERE.uniQure, headquartered in Amsterdam, the Netherlands, is a biotechnology company focused on the development of gene therapies for severe diseases, including Huntington's disease (HD).The Complaint alleges
More news about: Berger Montague
Feb 23, 2026, 09:00 ET Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Feb 23, 2026, 08:55 ET Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Jose Conejo-Garcia, M.D., Ph.D., Professor of Immunology in the
More news about: Anixa Biosciences, Inc.
Feb 23, 2026, 08:40 ET "Would You Clone Yourself for a Cure?" Clonell Unveils White Paper on Fundamental Cures for 34 Incurable Diseases Using 'Human Cloning' Technology
cloning has long been a subject of dystopian science fiction and a stringent ethical taboo. However, Clonell Therapeutics, Inc., a cutting-edge biotechnology company, is actively shaking the landscape of regenerative medicine by bringing this powerful, historically controversial technology into the clinical
More news about: Clonell Therapeutics, Inc.
Feb 23, 2026, 08:33 ET Consano Bio to Present at BIO Investment & Growth Summit 2026
Consano Bio, a clinical-stage biotechnology company advancing novel therapeutics designed to address serious pain conditions, today announced that CEO Andrew Hall will present at the
More news about: Consano Bio
Feb 23, 2026, 08:00 ET Braveheart Bio to Participate in TD Cowen 46th Annual Health Care Conference
SAN FRANCISCO, Feb. 23, 2026 /PRNewswire/ -- Braveheart Bio, a clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions, today announced that it will participate in the TD
More news about: Braveheart Bio
Feb 23, 2026, 07:00 ET PlantArcBio and Helix Sementes e Biotecnologia (Agroceres Group Company) Announce Licensing Collaboration to Advance High-Yield, Drought-Resilient Corn in South America
GIVAT CHEN, Israel and RIO CLARO, Brazil, Feb. 23, 2026 /PRNewswire/ -- PlantArcBio, an ag-biotechnology company pioneering precision biology for better crop performance, and Helix Sementes e Biotecnologia, a corn and sorghum seed company within
More news about: PlantArcBio and Agroceres Group
Feb 23, 2026, 07:00 ET Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02
Feb. 23, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Feb 23, 2026, 07:00 ET Promise Bio Launches Frontier Epiproteomic Innovation Grant, an R&D Access Initiative for Translational Epiproteomic Analysis
or additional laboratory procedures. Rooted in foundational research conducted at the Weizmann Institute of Science and featured in Nature Biotechnology in 2023, the proprietary technology allows for large-scale PTM profiling, helping researchers uncover disease mechanisms, tailor therapies, and
More news about: Promise Bio
Feb 23, 2026, 06:50 ET Functional Flour Market to Reach US$ 166.0 Billion by 2032 Expands Amid Rising Health Consciousness and Nutritional Innovation - Persistence Market Research
Nordmann in 2025A major development in the functional flour market was the new distribution agreement between French biotechnology firm Nutriearth and chemical distributor Nordmann to expand availability of N-utra, Nutriearth's mealworm-derived natural vitamin D3 functional
More news about: Persistence Market Research Pvt. Ltd.
Feb 23, 2026, 01:00 ET Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
Arrotex Pharmaceuticals.About Formosa Pharmaceuticals, Inc.Formosa Pharmaceuticals, Inc. (6838.TW) is a clinical stage biotechnology company with primary focus in the areas of ophthalmology and oncology. The company's proprietary nanoparticle formulation
More news about: Formosa Pharmaceuticals Inc.,
Feb 20, 2026, 13:06 ET Mecademic Secures Strategic Funding to Drive Global Expansion
next growth phase."Demand for Mecademic's micro-automation solutions is rising in sectors like electronics, optics, medical devices, and biotechnology. Its ultra-compact robotic arms allow manufacturers and labs to integrate high-speed, precise automation into confined spaces where traditional
More news about: Mecademic Industrial Robotics
Feb 20, 2026, 10:30 ET Sōlaria Biō Announces Study Demonstrating that the Microbe Blend in Bōndia™ Provides Maximum Bone Health Benefits
DensityBOSTON, Feb. 20, 2026 /PRNewswire/ -- Sōlaria Biō, a biotechnology company pioneering natural solutions for healthy aging, recently published the findings of a new open-label, randomized clinical study in
More news about: Sōlaria Biō
Feb 20, 2026, 09:15 ET AI Takes Flight: Five Companies Advancing Defense and Aerospace Intelligence
received a $75 million task order from the U.S. Air Force to advance biotechnology and smart materials under the Functional Responsive Experimentation for Systems and Humans (FRESH) program at Wright Patterson Air Force Base in
More news about: USA News Group
Feb 20, 2026, 08:19 ET Aramore Featured in Forbes for Pioneering NAD+ Innovation in Beauty
aramoreskincare.com and select retail partners nationwide.About AramoreFounded at the intersection of biotechnology and beauty, Aramore is a pioneering skincare brand focused on longevity through cellular health. Backed by scientific research from MIT and Harvard,
More news about: ARAMORE Skincare